Home / Tocilizumab / Austria
AT ATC L04AC07 · updated 2 Nov 2026
Tocilizumab shortage in Austria
Is there a Tocilizumab shortage in Austria?
Yes. As of 2 Nov 2026, 7 Tocilizumab products are reported short in Austria, the first since 11 Jun 2026. The company estimate for the return is 31 Mar 2027 (latest 31 Jul 2027). Main reason: increased demand.
Also short in Canada, Italy, Czechia, Japan. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Tyenne 162 mg Injektionslösung in einem Fertigpen, 4 Stück limited | Fresenius Kabi Deutschland GmbH | 11 Jun 2026 | not given | Increased demand Erhöhter Mehrbedarf |
| AT | Tyenne 162 mg Injektionslösung in einer Fertigspritze, 4 Stück | Fresenius Kabi Deutschland GmbH | 18 Aug 2026 | not given | Increased demand Erhöhter Mehrbedarf |
| AT | Tyenne 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung, 1 Stück limited | Fresenius Kabi Deutschland GmbH | 18 Aug 2026 | not given | Increased demand Erhöhter Mehrbedarf |
| AT | Tyenne 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung, 1 Stück limited | Fresenius Kabi Deutschland GmbH | 18 Aug 2026 | not given | Increased demand Erhöhter Mehrbedarf |
| AT | Tyenne 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung, 1 Stück limited | Fresenius Kabi Deutschland GmbH | 18 Aug 2026 | not given | Increased demand Erhöhter Mehrbedarf |
| AT | Avtozma 162 mg Injektionslösung in einer Fertigspritze, 4 Stück limited | Celltrion Healthcare Hungary Ltd. | 15 Sep 2026 | 31 Jul 2027 | Increased demand Erhöhter Mehrbedarf |
| AT | Avtozma 162 mg Injektionslösung in einem Fertigpen, 4 Stück limited | Celltrion Healthcare Hungary Ltd. | 22 Sep 2026 | 31 Mar 2027 | Increased demand Erhöhter Mehrbedarf |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).